The generation interval and season of birth do not affect age at first calving, birth weight and calving interval of Mozambican Angoni cattle.

The Angoni cattle breed's contribution to the country's economy is crucial, as it significantly contributes to animal draught power and meat supply, despite not being primarily used for milk production. Despite its importance, there is a lack of comprehensive research conducted to characterize this breed. This study aimed to investigate the impact of the generation interval (GI) and season of birth (SB) on key reproductive parameters, including age at first calving (AFC), birth weight (BW), and calving interval (CI) in angoni cattle. Data sourced from the Angónia Research Station (ARS) included records for 425 heifers' AFC, 1684 calves' BW, and 1272 cows' CI. The study calculated overall averages and explored the relationships between generation intervals, the season of birth, and the aforementioned reproductive traits. The mean values for AFC, BW, and CI were determined as 1475.40 days, 18.49 kg, and 634.62 days, respectively. The analysis revealed that both generation interval and season of birth exhibited weak relationships, and their influence did not yield significant effects on the reproductive traits under investigation (P > 0.05). The observed variability ranged from 0.37 to 0.46% for AFC, 0.10-0.01% for BW, and 0.11-0.26% for CI. In conclusion, this study determined that neither generation interval nor birth season significantly affected the age at first calving, birth weight, or calving interval in Angoni cattle.

Soybean oil addition to wheat bran-based diet improves laying hens' performance.

Background and Aim: Wheat bran (WB) is used extensively in animal feed. Despite its nutritional value, its use is limited because of its high-fiber content. We evaluated the effect of soybean oil on laying hen performance with maize meal partly replaced by WB. Materials and Methods: Thirty-six ISA Brown laying hens, 40 weeks old, were used in a completely randomized design in which laying hens were distributed in individual cages, with three replications of four birds and assigned to three treatments: T1 (basal diet), T2 (60% basal diet + 20% maize meal + 20% WB), and T3 (60% basal diet + 20% maize meal + 17.5% WB + 2.5% soybean oil). Results: Compared with the control group (T1), replacing 20% of yellow maize with WB (T2) did not affect average live weight, egg laying rate, soft-shelled egg production, egg mass, feed conversion per dozen eggs, or laying hen viability (p > 0.05). When 20% of the maize meal was replaced with WB, feed intake and feed conversion per egg mass increased (p < 0.05). Furthermore, adding 2.5% soybean oil to feed containing WB improved laying hen performance by significantly reducing feed conversion per egg mass (p < 0.05). Conclusion: Adding 2.5% soybean oil to diets containing WB instead of 17.5% yellow maize improved the feed conversion per egg mass performance of laying hens.

Microbiological assessment reveals that Salmonella, Shigella and Campylobacter infections are widespread in HIV infected and uninfected patients with diarrhea in Mozambique.

Diarrhea is an important cause of hospitalizations in Mozambique. However, little attention has been paid to the impact HIV infection on the prevalence or clinical manifestations of enteric bacterial infections. This study aimed to determine the prevalence of Salmonella spp., Shigella spp. and Campylobacter spp. in HIV-infected and HIV-uninfected patients with diarrhea, identify risk factors for infection, and explore the association between HIV status, viral load, and bacterial prevalence. We conducted a case-control study at the Centro de Saúde de Mavalane and Centro de Saúde 1° de Maio in Maputo, Mozambique, from November 2021 to May 2022. We recruited 300 patients, including 150 HIV-infected (cases) and 150 HIV-uninfected patients (controls), aged between 0-88 years, presenting with diarrhea. Stool samples were collected for bacterial isolation through culture, and for each HIV-infected patient, 4 ml of venous blood were obtained for viral load detection through PCR. A total of 129 patients (43.0%) had at least one bacterial infection. The prevalence of Salmonella spp., Shigella spp. and Campylobacter spp. was 33.0% (n = 99), 15.0% (n = 45) and 4.3% (n = 13), respectively. The prevalence of any bacterial infection did not differ significantly between HIV-infected (45.3%, n = 68) and HIV-uninfected patients (40.7%, = 61) (p = 0.414). Overall, having 2-3 symptoms of enteric disease (p = 0.008) and a basic education (p = 0.030) were factors associated with bacterial infection. Of the 148 patients for whom HIV-1 RNA levels were available, 115 had copy numbers ≤ 75. Another 13 had levels between 76 and 1,000 and the remaining 20 had an average of 327,218.45 copies/ml. Bivariate logistic regression found that Shigella spp. were associated with HIV (p = 0.038), although no association was found in the multivariate analysis. Enteric infections are common in both HIV-infected and -uninfected patients. Low schooling influences the occurrence of enteric infections, which highlights the need to raise awareness about their prevention.

A Systematic Review of In Vitro Activity of Medicinal Plants from Sub-Saharan Africa against Campylobacter spp.

INTRODUCTION: Campylobacter spp. are zoonotic bacteria that cause gastroenteritis in humans and may cause extraintestinal infections such as Guillain-Barré syndrome, reactive arthritis, and bacteremia. Resistance to antibiotics is an increasing concern in the Sub-Saharan Africa; thus, search for alternatives such as plant-based active ingredients is important in order to develop new drugs. OBJECTIVES: To present a systematic review of in vitro and in vivo studies of the antibacterial activity of medicinal plants from Sub-Saharan Africa against Campylobacter spp. Methodology. Studies published until March 2020 on medicinal plants used against Campylobacter spp. from each country of Sub-Saharan Africa were searched on PubMed, Science Direct, AJOL, and Google Scholar. Articles were selected based on the existence of information regarding in vitro and in vivo activity of medicinal plants against Campylobacter spp. RESULTS: A total of 47 medicinal plants belonging to 28 families were studied for in vitro activity against Campylobacter spp. No plant was studied in vivo. Plants from Fabaceae family were the most commonly studied. The plants with the strongest antimicrobial activities were Cryptolepis sanguinolenta and Terminalia macroptera. The root extracts from these plants were effective, and both had a minimal inhibitory concentration (MIC) of 25 µg/ml. Seven pure compounds were isolated and analyzed for activity against Campylobacter spp. The compound cryptolepine from C. sanguinolenta was the most effective with MIC values ranging between 6.25 and 25 µg/ml. CONCLUSION: Several native plants from the Sub-Saharan Africa region were studied for in vitro activity against Campylobacter spp. Some plants seemed very effective against the bacteria. Chemical compounds from three plants have been isolated and analyzed, but further studies are needed in order to produce new and effective drugs.

Epidemiology and antimicrobial resistance of Campylobacter spp. in animals in Sub-Saharan Africa: A systematic review.

INTRODUCTION: Low sanitary conditions characterize the rural and urban households in Sub-Saharan African region. Those environmental conditions propitiate the transmission of bacterial infections between animals and humans. Campylobacter spp. is a zoonotic bacterium and cause of human gastroenteritis worldwide, whose main symptom is diarrhea. It is normally found in the digestive tract of many farm animals as a commensal but some species cause diseases in animals. It is important to understand the occurrence of these bacteria in animals, as they may also play a role in transmission to humans. The main objective of this review was to describe the prevalence of Campylobacter in animals in Sub-Saharan Africa. We also report findings on antibiotic resistance. METHODS: We followed PRISMA guidelines to find studies about occurrence of Campylobacter spp. in animals in all countries from Sub-Saharan Africa. PubMed, Cochrane Library, CINAHL, African Index Medicus, African Journals Online, Google Scholar and Science Direct were searched for studies published between 2000 and 2019. RESULTS: We found 70 studies that described occurrence of Campylobacter spp. in animals in 18 out of 53 countries of Sub-Saharan Africa. Campylobacter jejuni and C. coli were the predominant species isolated. The majority of studies were found in Western Africa. Middle Africa had the lowest amount of data. Most records presented data from Nigeria (n = 25), South Africa (n = 14) and Tanzania (n = 11). Cattle and chickens appear to be important hosts and may be playing an important role in transmitting to humans. Most Campylobacter isolates were resistant to erythromycin (44%), ampicillin (39%), tetracycline (33%), nalidixic acid (31%) and ciprofloxacin (30%). CONCLUSION: Several studies about Campylobacter spp. in animals have been published in the last 19 years but information on the epidemiology of campylobacteriosis is scarce in most Sub-Saharan African countries. Antibiotic resistance is an increasing concern in many countries. Measures should be taken to prevent infection by this pathogen in the region and to control antibiotic resistance.

Serological evidence of avian encephalomyelitis virus and Pasteurella multocida infections in free-range indigenous chickens in Southern Mozambique.

A total of 398 serum samples from free-range indigenous chickens originating from four villages in Southern Mozambique were tested for the presence of avian encephalomyelitis virus (AEV) and Pasteurella multocida (PM) antibodies through commercial enzyme-linked immunosorbent assay (ELISA) kits. AEV and PM antibodies were detected in all villages surveyed. The proportion of positive samples was very high: 59.5% (95% confidence interval (CI) 51.7-67.7%) for AEV and 71.5% (95% CI 67.7-77.3%) for PM. Our findings revealed that these pathogens are widespread among free-range indigenous chickens in the studied villages and may represent a threat in the transmission of AEV and PM to wild, broiler or layer chickens in the region. Further research is warranted on epidemiology of circulating strains and impact of infection on the poultry industry.

Serological Screening Suggests Extensive Presence of Mycoplasma gallisepticum and Mycoplasma synoviae in Backyard Chickens in Southern Mozambique.

A total of 459 serum samples from unvaccinated backyard chickens originating from 4 villages in Mandlakazi district, Southern Mozambique, were tested for the presence of Mycoplasma gallisepticum and Mycoplasma synoviae antibodies through commercial enzyme-linked immunoabsorbent assay [ELISA] kits. Anti-MG and anti-MS antibodies were detected in all villages surveyed and the overall seroprevalence was 48.8% [95% CI 39.1-57.8] and 84.5% [95% CI 76.8-90.4], respectively. The risk of being seropositive for both diseases was higher [P < 0.05] in Chidenguele village than other villages. It is concluded that MG and MS serum antibodies are present in backyard chickens.